XML 45 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Summary of Significant Accounting Policies - Segments (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
USD ($)
Jun. 30, 2016
Jun. 30, 2017
USD ($)
item
Jun. 30, 2016
Dec. 31, 2016
USD ($)
Segment Information          
Number of operating segments | item     1    
Recent Accounting Pronouncements          
Prepaid and other current assets $ 4,758   $ 4,758   $ 5,386
Other assets $ 3,148   $ 3,148   $ 3,020
Bayer | Revenues percentage | Customer concentration          
Segment Information          
Percentages of revenue recognized       37.00%  
CytomX | Revenues percentage | Customer concentration          
Segment Information          
Percentages of revenue recognized 3.00% 10.00% 22.00% 5.00%  
Roche | Revenues percentage | Customer concentration          
Segment Information          
Percentages of revenue recognized 17.00% 80.00% 21.00% 49.00%  
Sanofi | Revenues percentage | Customer concentration          
Segment Information          
Percentages of revenue recognized 77.00%   53.00%    
Maximum | Accounting Standards Update 2014-09          
Recent Accounting Pronouncements          
Number of contracts requiring evaluation | item     20    
Federal | New accounting pronouncement | Accounting Standards Update 2016-09          
Recent Accounting Pronouncements          
Net deferred tax assets $ 9,200   $ 9,200    
Valuation allowance 9,200   9,200    
State | New accounting pronouncement | Accounting Standards Update 2016-09          
Recent Accounting Pronouncements          
Net deferred tax assets 1,200   1,200    
Valuation allowance $ 1,200   $ 1,200